 |
| Rick Klausner, Illumina's chief medical officer |
Illumina ($ILMN) is lending a hand to Ebola diagnostic efforts, teaming up with U.S. government officials and researchers at the Broad Institute to help scientists in West Africa track the virus and develop new tools to prevent its spread. The company is staying mum on financial details, but plans to train and outfit lab facilities with its next-generation genome sequencing technology to process heavy sample loads, Chief Medical Officer Rick Klausner said in a statement. Release | More